Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 84

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Review: Prospects for the Use of Extracts and Polysaccharides from Marine Algae to Prevent and Treat the Diseases Caused by Helicobacter pylori

Besednova, Natalya N., Zaporozhets, Tatyana S., Somova, Larisa M., Kuznetsova, Tatyana A.·2015·Helicobacter
DOI 10.1111/hel.12177
Open this paper in CoChat — free account

Abstract

Helicobacter pylori possesses a broad spectrum of pathogenic factors that allow it to survive and colonize the gastric mucosa, and thus, the pathogenetic targets, which have the same diversity, require search for and the development of alternative, effective, and innocuous means for the eradication of H. pylori. In recent years, fucoidans have been extensively studied due to the numerous interesting biological activities, including the anti‐adhesive, anti‐oxidative, antitoxic, immunomodulatory, anticoagulant, and anti‐infection effects. This review summarizes the data on the effects of extracts and sulfated polysaccharides of marine algae, mainly fucoidans, on pathogenic targets in Helicobacter infection. The pathogenetic targets for therapeutic agents after H. pylori infection, such as flagellas, urease, and other enzymes, including adhesins, cytotoxin A (VacA), phospholipase, and L‐8, are characterized here. The main target for the sulfated polysaccharides of seaweed is cell receptors of the gastric mucosa. This review presents the published data about the pleiotropic anti‐inflammatory effects of polysaccharides on the gastric mucosa. It is known that fucoidan and other sulfated polysaccharides from algae have anti‐ulcer effects, prevent the adhesion of H. pylori to, and reduce the formation of biofilm. The authors speculate that the effect of sulfated polysaccharides on the infectious process caused by H. pylori is related to their action on innate and adaptive immunity cells, and also anti‐oxidant and antitoxic potential. Presented in the review are materials indicated for the study of extracts and sulfated polysaccharides from seaweed during H. pylori infection, as these compounds are characterized by multimodality actions. Based on the analysis of literary materials in recent years, the authors concluded that fucoidan can be attributed to the generation of new candidates to create drugs intended for the inclusion in the scheme of eradication therapy of H. pylori infection.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/hel.12177

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 74

  1. Warren JR, 1983, Unidentified curved bacilli on gastric epithelium in active chronic gastritis, Lancet, 323, 1273
  2. Tsodikov GV, 2011, Achievements and prospects of studying Helicobacter pylori infection, Epidemiol Infect Dis, 2, 46
  3. 10.1111/hel.12077 · DOI
  4. Al‐Fawaeir S, 2013, Serum lipid profile in Helicobacter pylori infected patients, J Invest Biochem, 2, 132, 10.5455/jib.20130603084538 · DOI
  5. Maev IV, 2011, Clarithromycin as a core element of eradication therapy of diseases associated with Helicobacter pylori infection, Gastroenterology, 1, 88
  6. Tkach SM, 2009, H. pylori infection as the main cause of gastric carcinogenesis, Health Ukraini, 1, 32
  7. 10.3748/wjg.v11.i47.7499 · DOI
  8. Maev IV, 2013, Causes of inefficiency of anti‐Helicobacter pylori therapy, Rus J Gastroenterol Hepatol, 23, 62
  9. 10.1111/j.1574-695X.2007.00248.x · DOI
  10. Osipenko MF, 2013, Effectiveness of eradication therapy and patient compliance, Consilium Medicum, 8, 14
  11. Skvortsov VV, 2012, Topical issues of diagnosis and treatment of antral gastritis type B, Policlinic, 1, 102
  12. 10.1111/j.1523-5378.2012.00976.x · DOI
  13. 10.1590/S0036-36342009000900010 · DOI
  14. Yevstigneev IV, 2011, Infection caused by H. pylori: state of problems and prospects, Clin Immunol Allergol Infektol, 6, 14
  15. 10.1046/j.1365-2958.2000.01918.x · DOI
  16. 10.1111/j.1523-5378.2010.00759.x · DOI
  17. 10.4161/gmic.1.2.11991 · DOI
  18. 10.1128/IAI.01370-10 · DOI
  19. 10.1128/IAI.01443-13 · DOI
  20. 10.1155/2014/426309 · DOI
  21. 10.3748/wjg.v20.i6.1424 · DOI
  22. 10.1111/j.1365-2036.2012.05165.x · DOI
  23. Binkowska A, 2013, The role of biofilm formation in pathogenesis of Helicobacter pylori infections, Prz Gastroenterol, 8, 27
  24. Romanova YM, 2011, Bacterial biofilms as a natural form of existence of bacteria in the environment and the host, J Microbiol, 3, 99
  25. 10.1016/j.gassur.2005.12.009 · DOI
  26. Zaporozhets TS, 2006, Immunotropic and anticoagulant properties of fucoidan from the brown alga Fucus evanescens: prospects of application in medicine, J Microbiol, 3, 54
  27. 10.3390/md12020886 · DOI
  28. 10.1093/glycob/cwm014 · DOI · Paper page
  29. 10.1055/s-0033-1352015 · DOI
  30. Parakhonsky AP, 2009, Regulation of adhesion as a method of preventing infection, Int J Appl Basic Med Res, 5, 126
  31. 10.1016/S0928-8244(03)00228-1 · DOI · Paper page
  32. 10.4161/viru.24606 · DOI
  33. Henriksson S, 2012, Helicobacter Pylori – Multitalented Adaptation of Binding Properties, 52
  34. 10.1016/j.jscs.2012.03.002 · DOI
  35. 10.1007/s11595-010-0094-z · DOI
  36. Smolina TP, 2006, Decreased of microorganisms adhesion on uroepiteliya cells using polysaccharide isolated from marine proteobacteria Pseudoalteromonas nigrifaciens, J Microbiol, 3, 58
  37. 10.1089/act.2008.14304 · DOI
  38. Masato N, 2005, Effect of fucoidan from Cladosiphon ocamuranus (Okinawa Mozuku) on the eradication of H. pylori, Cell (Tokyo), 37, 452
  39. Lutau N, 2010, Effect of heparin, fucoidan and other polysaccharides on adhesion of entherohepatic Helicobacter species to murine macrophages, Appl Biochem Biotechnol, 19, 1
  40. 10.1016/j.lfs.2013.08.002 · DOI · Paper page
  41. Sinurat E, 2012, Fucoidan from brown seaweed and its bioactivity, Squalen, 7, 131
  42. 10.1016/j.intimp.2010.11.002 · DOI
  43. Amornlerdpison D, 2009, Gastroprotective activity of Padina minor Yamada, Chiang Mai J Sci, 36, 92
  44. Amornlerdpison D, 2007, Hypotensive activity of some marine algae, J Sci Res Chula, 363
  45. Amornlerdpison D, 2007, Antioxidant activity of Padina minor Yamada, KMITh Sci Technol, 7, 1
  46. 10.1016/j.tibtech.2012.11.004 · DOI
  47. Back HI, 2010, Effect of fucoidan supplementation on Helicobacter pylori in humans, FASEB J, 24, Ib 347
  48. 10.1111/j.1462-2920.2012.02810.x · DOI · Paper page
  49. 10.4236/abb.2013.42A037 · DOI
  50. 10.1128/IAI.00381-12 · DOI
  51. 10.3390/md9071293 · DOI
  52. 10.3390/md10040812 · DOI
  53. 10.3109/08923973.2012.707211 · DOI
  54. 10.3109/08923973.2012.742534 · DOI
  55. 10.1016/S1875-2136(09)72134-5 · DOI
  56. Galebskaya LV, 2003, Mechanisms of fucoidan action on human complement, Biomed Chem, 6, 542
  57. 10.1016/j.abb.2005.11.001 · DOI · Paper page
  58. 10.1016/j.fct.2011.04.020 · DOI · Paper page
  59. 10.3839/jabc.2012.035 · DOI
  60. Yoon WJ, 2009, Anti‐inflammatory activity of brown alga Dictiota dichotoma in murine macrophage RAW264.7 cells, J Med Plant Res, 3, 1
  61. 10.4314/tjpr.v10i2.66558 · DOI
  62. 10.1016/j.jnutbio.2009.03.013 · DOI
  63. 10.4314/tjpr.v11i1.6 · DOI
  64. 10.7150/ijms.8.56 · DOI
  65. 10.1023/A:1015399204069 · DOI
  66. Pattanayak SP, 2008, Hepatoprotective activity of the leaf extracts from Dendrophthoe falcate Ettingsh against carbon tetrachloride‐induced toxicity in wistar albino rates, Pharmacogn Mag, 4, 218
  67. 10.1016/S1995-7645(10)60168-X · DOI
  68. Vadlapudi V, 2012, Antioxidant activities of marine algae: a review, Int J Rec Sci Res, 3, 574
  69. Makarenkova ID, 2009, Sulfated polysaccharides from brown seaweed – inducers of dendritic cell maturation, Pacific Med J, 3, 36
  70. 10.1111/j.1523-5378.2012.00977.x · DOI
  71. 10.1111/j.1523-5378.2012.00991.x · DOI
  72. Makarenkova ID, 2012, Sulfated polysaccharides of brown seaweeds are ligands of Toll‐like receptors, Biomed Chem, 6, 75
  73. Dugina VV, 2011, Effect of immunomodulate therapy on lysozyme activity and severity of contamination of Helicobacter pylori in chronic gastric ulcer and duodenal ulcer, Modern Med Technol, 1, 138
  74. Konorev MR, 2012, Application of immunomodulator N‐acetylglucosamine‐N‐atsetilmuramildipeptid during the three‐component anti Helicobacter therapy, Therapeutic Archive, 12, 66

Cited by

See all 84

Metadata

Authors
Besednova, N. N., Zaporozhets, T. S., Somova, L. M., & Kuznetsova, T. A.
Affiliations
G.P. Somov Research Institute of Epidemiology and Microbiology Siberian Branch of the Russian Academy of Medical Sciences Vladivostok Russia
Venue
Helicobacter
Publisher
Wiley
Published
2015-02-08
Volume
20
Issue
2
Pages
89-97
ISSN
  • 1083-4389
  • 1523-5378
DOI
10.1111/hel.12177
Cited by
84
References
6
Language
en
Licence
onlinelibrary.wiley.com/termsAndConditions#vor (vor)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.